DJ-1 degrades transthyretin and an inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy

International Journal of Molecular Medicine

Volumn 19, Issue 6, 2007, Pages 885-893

  Koide Yoshida, Shizuyo ^a   Niki, Takeshi ^a   Ueda, Mitsuharu ^b   Himeno, Shingo ^b   Taira, Takahiro ^a   Iguchi Ariga, Sanae M M ^a   Ando, Yukio ^b   Ariga, Hiroyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

DJ 1; Familial amyloidotic polyneuropathy; Transthyretin

Indexed keywords

ISOENZYME; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PEPTIDE HYDROLASE; PREALBUMIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BACK; BLOOD; CELL CULTURE; CELL STRAIN 3T3; ENZYMOLOGY; FAMILIAL AMYLOID POLYNEUROPATHY; HEART MUSCLE; HUMAN; METABOLISM; MOUSE; NERVOUS TISSUE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; SECRETION;

AMYLOID NEUROPATHIES, FAMILIAL; ANIMALS; CELLS, CULTURED; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LUMBOSACRAL REGION; MICE; MYOCARDIUM; NERVE TISSUE; NIH 3T3 CELLS; ONCOGENE PROTEINS; OXIDATIVE STRESS; PEPTIDE HYDROLASES; PREALBUMIN; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 34548598264     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.6.885     Document Type: Article

References (41)

1. Buxbaum JN and Tagoe CE: The genetics of the amyloidoses. Rev Med 51: 543-569, 2000.
2. Merlini G and Bellotti V: Molecular mechanisms of amyloidosis. N Engl J Med 349: 583-596, 2003.
3. Sacchettini JC and Kelly JW: Therapeutic strategies for human amyloid diseases. Nat Rev Drug Discov 1: 267-275, 2002.
4. Kelly JW: The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol 8: 101-106, 1998.
5. Damas AM and Saraiva MJ: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies. J Struct Biol 130: 290-299, 2000.
6. Ando Y, Nakamura M and Araki S: Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62: 1057-1062, 2005.
7. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS and Buxbaum JN: Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in Black Americans. N Engl J Med 336: 466-473, 1997.
8. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SMM and Ariga H: DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509-513, 1997.
9. Bonifati V, Rizzu P, van Baren MJ, et al: Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. Science 299: 256-259, 2003. (Pubitemid 36131051)
10. Okada M, Matsumoto K, Niki T, Taira T, Iguchi-Ariga SMM and Ariga H: DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice. Biol Pharm Bull 25: 853-856, 2002. (Pubitemid 40022111)
11. Klinefelter GR, Welch JE, Perreault SD, et al: Localization of the sperm protein SP22 and inhibition of fertility in vivo and in vitro. J Androl 23: 48-63, 2002.
12. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S and Hanash SM: Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7: 3328-3335, 2001.
13. Miura K, Bowman ED, Simon R, et al: Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 62: 3244-3250, 2002.
14. Takahashi K, Taira T, Niki T, Seino C, Iguchi-Ariga SMM and Ariga H: DJ-1 positively regulates the androgen receptor by impairing the binding of PIASα to the receptor. J Biol Chem 276: 37556-37563, 2001. (Pubitemid 37384181)
15. Niki T, Takahashi-Niki K, Taira T, Iguchi-Ariga SMM and Ariga H: DJBP: A novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res 1: 247-261, 2003.
16. Xu J, Zhong N, Wang H, et al: The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Hum Mol Genet 14: 1231-1241, 2005.
17. Shinbo Y, Taira T, Niki T, Iguchi-Ariga SMM and Ariga H: DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Int J Oncol 26: 641-648, 2005.
18. Nishinaga H, Takahashi-Niki K, Taira T, Andreadis A, Iguchi-Ariga SMM and Ariga H: Expression profiles of genes in DJ-1-knockdown and L166P DJ-1 mutant cells. Neurosci Lett 390: 54-59, 2005.
19. Ooe H, Taira T, Iguchi-Ariga SMM and Ariga H: Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol Sci 88: 114-126, 2005. (Pubitemid 41548753)
20. Taira T, Saito Y, Niki T, Iguchi-Ariga SMM, Takahashi K and Ariga H: DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218, 2004. (Pubitemid 38401204)
21. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H and Mizusawa H: Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312: 1342-1348, 2003.
22. Canet-Aviles RM, Wilson MA, Miller DW, et al: The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101: 9103-9108, 2004.
23. Martinat C, Shendelman S, Jonason A, et al: Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary Parkinsonism. PLoS Biol 2: e327, 2004.
24. Honbou K, Suzuki NN, Horiuchi M, Niki T, Taira T, Ariga H and Inagaki F: The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J Biol Chem 278: 31380-31384, 2003.
25. Olzmann JA, Brown K, Wilkinson KD, et al: Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem 279: 8506-8515, 2004.
26. Shendelman S, Jonason A, Martinat C, Leete T and Abeliovich A: DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2: e362, 2004.
27. Zhou W, Zhu M, Wilson MA, Petsko GA and Fink AL: The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol 356: 1036-1048, 2006. (Pubitemid 43145955)
28. Ito G, Ariga H, Nakagawa Y and Iwatsubo T: Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1. Biochem Biophys Res Commun 339: 667-672, 2006. (Pubitemid 41739719)
29. Moore DJ, Zhang L, Dawson TM and Dawson VL: A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homooligomerization. J Neurochem 87: 1558-1567, 2003.
30. Shinbo Y, Niki T, Taira T, et al: Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities. Cell Death Diff 13: 96-108, 2006.
31. Wilson MA, Collins JL, Hod Y, Ringe D and Petsko GA: e 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc Natl Acad Sci USA 100: 9256-9261, 2003.
32. Kinumi T, Kimata J, Taira T, Ariga H and Niki E: Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317: 722-728, 2004.
33. Takahashi-Niki K, Niki T, Taira T, Iguchi-Ariga SMM and Ariga H: Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. Biochem Biophys Res Commun 320: 389-397, 2004. (Pubitemid 38798879)
34. Ooe H, Iguchi-Ariga SMM and Ariga H: Establishment of specific antibodies that recognize C106-oxidized DJ-1. Neurosci Lett 404: 166-169, 2006.
35. Nakamura M, Yamashita T, Ueda M, et al: Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology 65: 1051-1056, 2005.
36. Yamashita T, Ando Y, Katsuragi S, et al: Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys. Muscle Nerve 31: 41-45, 2005.
37. Ando Y, Nyhlin N, Suhr O, et al: Oxidative stress is found in amyloid deposits in systemic amyloidosis. Biochem Biophys Res Commun 232: 497-502, 1997.
38. Li HM, Niki T, Taira T, Iguchi-Ariga SMM and Ariga H: Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress. Free Radic Res 39: 1091-1099, 2005.
39. Moore DJ, Zhang L, Troncoso J, et al: Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum Mol Genet 14: 71-84, 2005.
40. Bandopadhyay R, Kingsbury AE, Cookson M, et al: The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127: 420-430, 2004.
41. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF and Sanchez JC: PARK7 and nucleotide diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 51: 2043-2051, 2005.